Related references
Note: Only part of the references are listed.Reduced-intensity conditioning follow by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders
Ginna G. Laport et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Lenalidomide as induction therapy before allogeneic stem cell transplantation in a patient with proliferative CMML-2 and del(5q) not involving the EGR1 locus
Gustav Carus
LEUKEMIA (2007)
Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation
Christoph Schmid et al.
BLOOD (2006)
Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemia
M Elliott et al.
BONE MARROW TRANSPLANTATION (2006)
Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia
DMB Kerbauy et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia
WK Hofmann et al.
ANNALS OF HEMATOLOGY (2004)
Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia
N Kröger et al.
ANNALS OF HEMATOLOGY (2003)
Evaluating the prognosis of patients with myelodysplastic syndromes
C Aul et al.
ANNALS OF HEMATOLOGY (2002)
Allogeneic stem cell transplantation of adult chronic myelomonocytic leukaemia.: A report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
N Kröger et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Share Paper
